Logo
K. Johra, "Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy", Scientific Reports. 2.
K. Johra, "Whole-Exome Sequencing Reveals Migraine-Associated Novel Functional Variants in Arab Ancestry Females: A Pilot Study", Brain sciences. 3.
K. Johra, "FMS-like tyrosine kinase-3 (FLT3) inhibitors with better binding affinity and ADMET properties than sorafenib and gilteritinib against acute myeloid leukemia: in silico studies", JOURNAL OF BIOMOLECULAR STRUCTURE AND DYNAMICS. 1.
K. Johra, "State-of-the-art tools to elucidate the therapeutic potential of TAT-peptide (TP) conjugated repurposing drug against SARS-CoV-2 spike glycoproteins", Current Pharmaceutical Design. Volume 28. 3.
K. Johra, "Molecular insight into the antiglycating and antiaggregating potential of ferulic acid with BSA", Monatshefte für Chemie/Chemical Monthly. Issue 153. 4.
K. Johra, "Development of gold nanoparticle-based biosensors for COVID-19 diagnosis", Beni-Suef University Journal ofBasic and Applied Sciences. Volume 11. 4.
K. Johra, "Human Monkeypox- An Update", Indo Global Journal of Pharmaceutical Sciences,. Volume 12.
K. Johra, "Anti-proliferative effects of a polyherbal formulation on HL-60, HCT-116, and HeLa cell lines: a docking simulation and response surface design-aided study", Frontiers in Chemistry. Volume 13. 2025.
K. Johra, "Prevalence and Classification of Anemia among Renal Failure Patients of Al Majmaah and Al Zulfi Hospitals, Riyadh, Saudi Arabia", Clinical Laboratory. Volume 71. 2025.
K. Johra, "Evaluation of ABL90 and ABL800 Radiometer Blood Gas Analyzers: Challenges and Applications in Point-of-Care Cancer Diagnostics in Saudi Arabia", Healthcare. Volume 13. Issue 3. 2025.
K. Johra, "Old” and current antimalarial drugs, mechanism of action, significance of fever and therapeutic hyperthermia", Reviews on Clinical Pharmacology and Drug Therapy. Volume 22. 2025.
K. Johra, "Therapeutic potential of Laurus nobilis extract by experimental and computational approaches: phenolic content and bioactivities for antioxidant, antidiabetic, and anticholinergic properties", Frontiers in Chemistry. Volume 13. 2025.
K. Johra, "Bioinformatics-Driven Structural and Pharmacological Analysis of SLITRK1 in Tourette Syndrome: Impact of S656M Mutation Using Molecular Dynamics, Docking, and Reinforcement Learning.", Computation. Volume 13. Issue 2. 2025.
K. Johra, M. Althomari, "Significance of NAT in the Identification of HBV Infections and HCV Infections Among Serologically Negative Blood Donors in Hail, Saudi Arabia", Clinical Laboratory. Volume 71. Issue 1. 2025.
K. Johra, "Exploring the antifungal potential of Cannabis sativa-derived stilbenoids and cannabinoids against novel targets through in silico protein interaction profiling", Frontiers in Chemistry. Volume 12. 2025.
K. Johra, "Lotus seed (Nelumbinis semen) extract: anticancer potential and chemoprofiling by in vitro, in silico and GC-MS studies", Frontiers in Chemistry. Volume 12. 2024.
K. Johra, "Investigation of antibacterial and antifungal properties of benzene sulfonamide derivatives by experimental and computational studies", Chemical Physics Impact. Volume 9. 2024.
K. Johra, "Dietary polyphenols: review on chemistry/sources, bioavailability/metabolism, antioxidant effects, and their role in disease management", Antioxidants. Volume 13. Issue 4. 2024.
Logo
Logo